CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine
- DOI
- 10.1016/j.jmccpl.2026.100869
- Published
- 2026-12
- Container
- Journal of Molecular and Cellular Cardiology Plus
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jmccpl.2026.100869,
title = {CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine},
author = {Adna Ašić and Yvan Devaux and Miron Sopić and Amela Jusić and Lemana Spahić and Rui Vitorino and Damir Marjanović and Konstantin Tashkov and Theodora Katsila and Amra Džuho and Kanita Karađuzović-Hadžiabdić},
year = {2026},
journal = {Journal of Molecular and Cellular Cardiology Plus},
doi = {10.1016/j.jmccpl.2026.100869},
url = {https://doi.org/10.1016/j.jmccpl.2026.100869}
}RIS
TY - JOUR TI - CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine AU - Adna Ašić AU - Yvan Devaux AU - Miron Sopić AU - Amela Jusić AU - Lemana Spahić AU - Rui Vitorino AU - Damir Marjanović AU - Konstantin Tashkov AU - Theodora Katsila AU - Amra Džuho AU - Kanita Karađuzović-Hadžiabdić PY - 2026 JO - Journal of Molecular and Cellular Cardiology Plus DO - 10.1016/j.jmccpl.2026.100869 UR - https://doi.org/10.1016/j.jmccpl.2026.100869 ER -
APA
Ašić, A., Devaux, Y., Sopić, M., Jusić, A., Spahić, L., Vitorino, R., Marjanović, D., Tashkov, K., Katsila, T., Džuho, A., & Karađuzović-Hadžiabdić, K. (2026). CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine. Journal of Molecular and Cellular Cardiology Plus. https://doi.org/10.1016/j.jmccpl.2026.100869
Source records
- crossref · retrieved 2026-11-06T20:41:12.980Z